Viral Latency
Viral Latency - Related Videos
12:22
A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation
0 Views •
Cited by 49 •
2012
The protocol describes an efficient and reproducible model system to study herpes simplex virus type 1 (HSV-1) latency and reactivation. The assay employs homogenous sympathetic neuron cultures and allows for the molecular dissection of virus-neuron interactions using a variety of tools including RNA interference and expression of recombinant proteins.
01:16
Psychosexual Stages of Personality: Latency
0 Views •
2025
Following the phallic stage in Freud's theory of psychosexual development, children enter a phase called the latency period, which lasts from approximately six to twelve years of age. Unlike earlier stages, where sexual impulses played a central role, Freud believed these impulses are repressed during the latency period, becoming part of the unconscious. This stage is often described as a time of psychological calm after the turbulence of the phallic stage. The latency period is not considered...
00:57
Viral Recombination
0 Views •
2019
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment. Viral Recombination Can Create New Diseases Some diseases can infect multiple species. For example, pigs can be infected by some human and...
00:56
Viral Structure
0 Views •
2019
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid. Structural Classes of Viruses Many criteria are used to classify viruses, including capsid design. Most viruses...
13:45
Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
0 Views •
Cited by 84 •
2011
The Virochip is a pan-viral microarray designed to simultaneously detect all known viruses as well as novel viruses on the basis of conserved sequence homology. Here we demonstrate how to run a Virochip assay to analyze clinical samples for the presence of both known and unknown viruses.
FAQs
Restricted viral gene expression limits the activity needed for productive replication, while cellular regulation helps keep the viral genome in a low-activity state. These controls reduce the formation of infectious particles and help prevent immediate cell destruction. Their combined effect allows the infection to persist until changes in cellular conditions or immune control permit renewed viral activity.
During latency, a viral genome may remain as an episome, meaning it persists separately from host chromosomes, or it may integrate into host DNA. These two arrangements describe different forms of genome persistence within the cell. Recognizing this distinction helps explain how viral genetic material remains available for restricted expression and possible reactivation.
Immune control is one factor that suppresses active viral replication during latency. If that control changes, the balance maintaining restricted viral activity may be disrupted, allowing reactivation. This relationship helps explain why latent infections can recur rather than simply disappear, and why immune regulation is important when investigating persistent viral infections.
An actively replicating infection produces infectious particles more readily and may damage cells as replication proceeds. In contrast, latency is associated with restricted viral activity, few or no infectious particles, and avoidance of immediate cell destruction. Comparing these states helps researchers distinguish persistence from ongoing productive replication and interpret why symptoms or infectious output may change over time.
Research on Viral Latency helps connect the continued presence of viral genetic material with infections that persist or return after periods of limited activity. It also clarifies how restricted replication, cellular regulation, and immune evasion contribute to recurrence. These insights provide a biological basis for explaining why an infection can remain clinically relevant without constant production of infectious particles.
Latent viral reservoirs are important because viral genetic material can remain in host cells even when active production of infectious particles is limited. Consequently, antiviral research must consider persistence as well as immediate replication. Understanding these reservoirs guides strategies aimed at addressing the source of recurring infection and may also clarify how some viruses contribute to long-term disease and cancer.